Drew Pardoll

Drew M.
Pardoll was the founder of Amplimmune, Inc. (founded 2007) where the title held was Director from 2009 to 2011.
Dr. Pardoll is the founder of Jounce Therapeutics, Inc. (founded 2013).
Dr. Pardoll is the founder of TRex Bio, Inc. (founded 2018).
Dr. Pardoll is the founder of Potenza Therapeutics, Inc. (founded 2014) and holds the title Member-Scientific Advisory Board since 2014.
Dr. Pardoll is also the founder of Clasp Therapeutics, Inc.,Tizona Therapeutics, Inc.,Enara Bio Ltd...
Dr. Pardoll is currently Director at DNAtrix, Inc., Director at The Sidney Kimmel Comprehensive Cancer Center since 2009, Director at Dracen Pharmaceuticals, Inc., Professor at The Johns Hopkins University, and Venture Partner at Catalio Capital Management LP.
Formerly, Dr. Pardoll was on the Scientific Advisory Board at Five Prime Therapeutics, Inc. Dr. Pardoll earned a doctorate from The Johns Hopkins University in 1982.